Sarepta Therapeutics, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$116.9M
Doctors Paid
1,587
Transactions
21,423
2024 Total
$17.2M
Payment Breakdown by Category
Research$103.9M (88.9%)
Consulting$6.0M (5.1%)
Royalty/License$4.5M (3.8%)
Travel$927,060 (0.8%)
Food & Beverage$193,459 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $103.9M | 13,971 | 88.9% |
| Consulting Fee | $6.0M | 1,201 | 5.1% |
| Royalty or License | $4.5M | 64 | 3.8% |
| Grant | $1.2M | 53 | 1.0% |
| Travel and Lodging | $927,060 | 1,773 | 0.8% |
| Food and Beverage | $193,459 | 4,224 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $137,054 | 75 | 0.1% |
| Education | $16,385 | 60 | 0.0% |
| Space rental or facility fees (teaching hospital only) | $2,545 | 2 | 0.0% |
Payments by Type
Research
$103.9M
13,971 transactions
General
$13.0M
7,452 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| 4045-301 | $21.0M | 3 | 903 |
| 4658-301 | $13.0M | 0 | 501 |
| SRP-9001-301 | $12.3M | 0 | 5,501 |
| SRP-9001-102 | $5.8M | 1 | 139 |
| SRP-9001-103 | $5.7M | 2 | 1,213 |
| SRP-5051-201 | $3.0M | 0 | 211 |
| SRP-9001-303 | $3.0M | 15 | 2,164 |
| Nationwide SRA | $3.0M | 0 | 14 |
| 4658-203 | $2.2M | 0 | 90 |
| 5051-201 | $1.9M | 1 | 141 |
| 4658-402 | $1.7M | 1 | 225 |
| 9001-102 | $1.5M | 0 | 10 |
| SRP-9001-305 | $1.3M | 0 | 833 |
| 4658-403 | $1.3M | 0 | 538 |
| 4045-101 | $1.2M | 2 | 57 |
| 4658-202 | $1.2M | 0 | 72 |
| 5051-102 | $1.2M | 0 | 206 |
| Research Institute at Nationwide SRA | $1.1M | 0 | 6 |
| 4658-204 | $986,509 | 0 | 43 |
| Leveraging large-scale genomic and clinical data to characterize rare, pathogenic mutations associated with dilated cardiomyopathy | $919,598 | 0 | 3 |
| SRP-LGMD-501-NHS | $916,841 | 0 | 131 |
| SRP-9003-301 | $898,996 | 1 | 91 |
| Sponsored Research Agreement - DMD | $852,155 | 0 | 31 |
| SRP-9003-102 | $613,033 | 0 | 37 |
| Phase IV Golodirsen | $595,541 | 0 | 4 |
| SRA with Duke for exosome gene editing | $563,500 | 0 | 2 |
| TESTING SARCOSPAN AS A THERAPEUTIC AND BIOMARKER FOR SARCOGLYCA | $487,797 | 0 | 3 |
| Powell Gene Therapy | $479,977 | 0 | 3 |
| Gene therapy approach to treat arrhythmias using MYBPC3 | $445,069 | 0 | 2 |
| Sponsored Research Agreement - CMT | $430,473 | 0 | 20 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Craig Mcdonald, M.d, M.D | Pediatric Rehabilitation Medicine | Sacramento, CA | $883,618 | $0 |
| Perry Shieh, Md, MD | Neuromuscular Medicine | Los Angeles, CA | $501,507 | $0 |
| Dr. Crystal Proud, M.d, M.D | Neurology with Special Qualifications in Child Neurology | Norfolk, VA | $392,398 | $0 |
| Dr. Chamindra Laverty, M.d, M.D | Neuromuscular Medicine | San Diego, CA | $302,347 | $0 |
| Dr. Aravindhan Veerapandiyan, Md, MD | Neurology with Special Qualifications in Child Neurology | Little Rock, AR | $278,573 | $0 |
| Nancy Kuntz, M.d, M.D | Neurology with Special Qualifications in Child Neurology | Chicago, IL | $265,309 | $0 |
| Jerry Mendell, Md, MD | Neurology | Columbus, OH | $224,933 | $0 |
| Emma Ciafaloni, Md, MD | Vascular Neurology | Rochester, NY | $189,438 | $0 |
| Dr. Matthew Harmelink, M.d, M.D | Pediatrics | Milwaukee, WI | $114,309 | $0 |
| Kathryn Mosher, M.d, M.D | Physical Medicine & Rehabilitation | Akron, OH | $108,508 | $0 |
| Joseph Bonventre, Md Phd, MD PHD | Nephrology | Boston, MA | $104,218 | $0 |
| Dr. Katherine Mathews, Md, MD | Neuromuscular Medicine | Iowa City, IA | $103,626 | $0 |
| Unknown Provider | — | — | $102,600 | $0 |
| Dr. Thomas Kinane, Md, MD | Pediatrics | Boston, MA | $101,032 | $0 |
| Anne Connolly, Md, MD | Neurology with Special Qualifications in Child Neurology | Columbus, OH | $99,554 | $0 |
| Dr. Howard Worman, M.d, M.D | Gastroenterology | New York, NY | $93,612 | $0 |
| Ashutosh Kumar, M.d, M.D | Student in an Organized Health Care Education/Training Program | Hershey, PA | $89,754 | $0 |
| Basil Darras, M.d, M.D | Neurology with Special Qualifications in Child Neurology | Boston, MA | $87,756 | $0 |
| Kan Hor, M.d, M.D | Pediatric Critical Care Medicine | Columbus, OH | $86,271 | $0 |
| Erika Finanger, M.d, M.D | Neurology with Special Qualifications in Child Neurology | Portland, OR | $84,286 | $0 |
| Partha Ghosh, Md, MD | Pediatrics | Rochester, MN | $83,164 | $0 |
| Hoda Abdel-Hamid, Md, MD | Pediatrics | Pittsburgh, PA | $77,731 | $0 |
| John Brandsema, Md, MD | Neurology with Special Qualifications in Child Neurology | Philadelphia, PA | $76,458 | $0 |
| Gyula Acsadi, Md, MD | Pediatrics | Detroit, MI | $76,276 | $0 |
| Ana Tesi Rocha, Md, MD | Neurology with Special Qualifications in Child Neurology | Palo Alto, CA | $71,832 | $0 |
Ad
Top Products
- EXONDYS 51 $10.8M
- Exondys 51 $6.1M
Associated Products (5)
- EXONDYS 51 $10.8M
- Exondys 51 $6.1M
- Amondys 45 $4.8M
- Vyondys 53 $2.8M
- Elevidys $377,981
Payment Categories
- Food & Beverage $193,459
- Consulting $6.0M
- Travel & Lodging $927,060
- Research $103.9M
- Royalties $4.5M
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. has made $116.9M in payments to 1,587 healthcare providers, recorded across 21,423 transactions in the CMS Open Payments database. In 2024, the company paid $17.2M. The top product by payment volume is EXONDYS 51 ($10.8M).
Payments were distributed across 101 medical specialties. The top specialty by payment amount is Neurology with Special Qualifications in Child Neurology ($2.0M to 155 doctors).
Payment categories include: Food & Beverage ($193,459), Consulting ($6.0M), Research ($103.9M), Travel & Lodging ($927,060), Royalties ($4.5M).
Sarepta Therapeutics, Inc. is associated with 5 products in the CMS Open Payments database, including EXONDYS 51, Exondys 51, and Amondys 45.